Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Amortization - Intangibles (2016 - 2018)

Ironwood Pharmaceuticals' Amortization - Intangibles history spans 3 years, with the latest figure at $1.2 million for Q3 2018.

  • On a quarterly basis, Amortization - Intangibles fell 38.9% to $1.2 million in Q3 2018 year-over-year; TTM through Dec 2018 was $8.1 million, a 30.53% increase, with the full-year FY2018 number at $8.1 million, up 30.53% from a year prior.
  • Amortization - Intangibles hit $1.2 million in Q3 2018 for Ironwood Pharmaceuticals, down from $3.5 million in the prior quarter.
  • Over the last five years, Amortization - Intangibles for IRWD hit a ceiling of $3.5 million in Q4 2017 and a floor of $420000.0 in Q1 2017.
  • Historically, Amortization - Intangibles has averaged $2.2 million across 3 years, with a median of $2.5 million in 2016.
  • Biggest five-year swings in Amortization - Intangibles: tumbled 60.47% in 2017 and later soared 727.62% in 2018.
  • Tracing IRWD's Amortization - Intangibles over 3 years: stood at $3.3 million in 2016, then grew by 5.33% to $3.5 million in 2017, then crashed by 66.66% to $1.2 million in 2018.
  • Business Quant data shows Amortization - Intangibles for IRWD at $1.2 million in Q3 2018, $3.5 million in Q2 2018, and $3.5 million in Q1 2018.